Literature DB >> 16399774

Heart rate response during exercise test and cardiovascular mortality in middle-aged men.

Kai P Savonen1, Timo A Lakka, Jari A Laukkanen, Pirjo M Halonen, Tuomas H Rauramaa, Jukka T Salonen, Rainer Rauramaa.   

Abstract

AIMS: The objective is to study whether a heart rate (HR) response during exercise test independently predicts cardiovascular disease (CVD) mortality. METHODS AND
RESULTS: The subjects were a representative sample of 1378 men, 42-61 years of age, from eastern Finland with neither prior coronary heart disease (CHD) nor use of beta-blockers at baseline. HR was measured at rest and during a maximal, symptom-limited exercise test at 20, 40, 60, 80, and 100% of maximal workload. During an average follow-up of 11.4 years, there were 56 deaths due to CVD. The slope of HR increase during exercise test was steeper in survivors when compared with those who died due to CVD during follow-up (P<0.001), and the difference in the steepness of HR slope between the groups was the strongest at interval 40-100% (P<0.001). In Cox-multivariable models, maximal HR-HR at 40% workload as a continuous variable was inversely associated with CVD (P=0.04), CHD (P=0.004), and all-cause (P=0.002) mortality after adjustment for known risk factors for CVD death.
CONCLUSION: By considering an HR response throughout an exercise test, we found that a blunted HR increase at 40-100% of maximal workload was associated with increased CVD mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16399774     DOI: 10.1093/eurheartj/ehi708

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

3.  Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis.

Authors:  Dongfeng Zhang; Xiaoli Shen; Xin Qi
Journal:  CMAJ       Date:  2015-11-23       Impact factor: 8.262

4.  Usefulness of the integrated scoring model of treadmill tests to predict myocardial ischemia and silent myocardial ischemia in community-dwelling adults (from the Rancho Bernardo study).

Authors:  Joong-Il Park; So-Young Shin; Sue K Park; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2015-01-31       Impact factor: 2.778

Review 5.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

6.  Hactive: a smartphone application for heart rate profiling.

Authors:  Adam Goldberg; Joshua W K Ho
Journal:  Biophys Rev       Date:  2020-07-14

7.  β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Authors:  Marcus Dörr; Carsten O Schmidt; Thomas Spielhagen; Alexa Bornhorst; Katharina Hentschel; Christina Franz; Klaus Empen; Thomas Kocher; Scott R Diehl; Heyo K Kroemer; Henry Völzke; Ralf Ewert; Stephan B Felix; Dieter Rosskopf
Journal:  Pharmacogenomics       Date:  2010-09       Impact factor: 2.533

8.  Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases: a meta-analysis.

Authors:  Dongfeng Zhang; Weijing Wang; Fang Li
Journal:  CMAJ       Date:  2016-08-22       Impact factor: 8.262

Review 9.  Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms.

Authors:  Paolo Palatini
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Physical activity and hemodynamic reactivity in chronic kidney disease.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.